NCT03400111

Brief Summary

Patients with class I malocclusion who have mild to moderate crowding will be treated in this study. The efficacy of low level laser therapy and Panadol-extra® in relieving pain due to orthodontic treatment will be assessed. The effect of these two interventions on oral-health related quality of life during all stages of orthodontic treatment will be explored, i.e. at the following stages: (1) separation between teeth, (2) archwire changing, (3) bonding of brackets, (4) removal of the fixed appliances. There are three groups :

  1. 1.a group of patient being irradiated with low-level laser therapy (LLLT) at specific time points to relieve pain and discomfort.
  2. 2.a group of patient in which pain control will be accomplished by prescribing Panadol Extra tablets in a regular manner.
  3. 3.a group of patients in which nothing will be given to them during the course of treatment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 15, 2017

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

January 9, 2018

Completed
8 days until next milestone

First Posted

Study publicly available on registry

January 17, 2018

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 15, 2019

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2019

Completed
Last Updated

July 18, 2019

Status Verified

July 1, 2019

Enrollment Period

1.5 years

First QC Date

January 9, 2018

Last Update Submit

July 16, 2019

Conditions

Outcome Measures

Primary Outcomes (7)

  • Change in Levels of Pain and Discomfort_Separation

    Patients will be given a rating numeric scale (RNS) to show their level of pain and discomfort after performing the first step in orthodontic installation of the appliance, i.e. the separation stage where separators are placed between the molar teeth on both sides of the jaw and in both jaws. Separators are placed for seven days before cementing the bands (that surround the molar teeth).

    (1) one hour following insertion of separators, (2) 24 hours, (3) 2 days, (4) seven days, (5) next meeting which is expected to be within 14 to 21 days.

  • Change in Levels of Pain and Discomfort_FirstArch

    Patients will be given a rating numeric scale (RNS) to show their level of pain and discomfort after banding the molars and bonding the rest of the dental arches. Brackets are to be placed and the first archwire will be engaged. Assessment will be made at this stage which is called 'First Arch Placement'.

    (1) one hour following insertion of separators, (2) 24 hours, (3) 2 days, (4) seven days, (5) next meeting which is expected to be within 14 to 21 days.

  • Change in Levels of Pain and Discomfort_SecondArch

    Patients will be given a rating numeric scale (RNS) to show their level of pain and discomfort after inserting the second arch in the sequence of arches of the orthodontic treatment. Assessment will be made at this stage which is called 'Second Arch Placement'.

    (1) one hour following insertion of separators, (2) 24 hours, (3) 2 days, (4) seven days, (5) next meeting which is expected to be within 14 to 21 days.

  • Change in Levels of Pain and Discomfort_ThirdArch

    Patients will be given a rating numeric scale (RNS) to show their level of pain and discomfort after inserting the third arch in the sequence of arches of the orthodontic treatment. Assessment will be made at this stage which is called 'Third Arch Placement'.

    (1) one hour following insertion of separators, (2) 24 hours, (3) 2 days, (4) seven days, (5) next meeting which is expected to be within 14 to 21 days.

  • Change in Levels of Pain and Discomfort_FouthArch

    Patients will be given a rating numeric scale (RNS) to show their level of pain and discomfort after inserting the fourth arch in the sequence of arches of the orthodontic treatment. Assessment will be made at this stage which is called 'Fourth Arch Placement'.

    (1) one hour following insertion of separators, (2) 24 hours, (3) 2 days, (4) seven days, (5) next meeting which is expected to be within 14 to 21 days.

  • Change in Levels of Pain and Discomfort_LastArch

    Patients will be given a rating numeric scale (RNS) to show their level of pain and discomfort after inserting the fifth (i.e. the last) arch in the sequence of arches of the orthodontic treatment. Assessment will be made at this stage which is called 'Last Arch Placement'.

    (1) one hour following insertion of separators, (2) 24 hours, (3) 2 days, (4) seven days, (5) next meeting which is expected to be within 14 to 21 days.

  • Change in Levels of Pain and Discomfort_Debonding

    Patients will be given a rating numeric scale (RNS) to show their level of pain and discomfort after appliance removal (i.e. taking off all the braces and bands). Assessment will be made at this stage which is called 'Appliance Removal'.

    (1) one hour following insertion of separators, (2) 24 hours, (3) 2 days, (4) seven days, (5) next meeting which is expected to be within 14 to 21 days.

Secondary Outcomes (7)

  • Change in oral-health-related quality of life_Separation

    (1) one week following separation, (2) at the following clinical visit which is usually expected to occur within 14 to 21 days.

  • Change in oral-health-related quality of life_FirstArch

    (1) one week following archwire engagement, (2) at the following clinical visit which is usually expected to occur within 14 to 21 days.

  • Change in oral-health-related quality of life_SecondArch

    (1) one week following archwire engagement, (2) at the following clinical visit which is usually expected to occur within 14 to 21 days.

  • Change in oral-health-related quality of life_ThirdArch

    (1) one week following archwire engagement, (2) at the following clinical visit which is usually expected to occur within 14 to 21 days.

  • Change in oral-health-related quality of life_FourthArch

    (1) one week following archwire engagement, (2) at the following clinical visit which is usually expected to occur within 14 to 21 days.

  • +2 more secondary outcomes

Other Outcomes (1)

  • Psychological General Well-being

    One week before performing the first step in Orthodontic Appliance Installation (i.e. one week before separation)

Study Arms (3)

Low-level laser therapy

EXPERIMENTAL

Patients upper and lower jaws will be irradiated with low-level laser therapy at specific points on the alveolus around the teeth from the vestibular and lingual sides. This group of patients will be followed up till the end of treatment.

Radiation: low-level laser therapy

Panadol-extra

EXPERIMENTAL

Patients will be given Panadol-extra (565 mg: 500 mg paracetamol and 65 mg caffeine) at specific time points to control pain and discomfort during orthodontic treatment. This group of patients will be followed up till the end of treatment.

Drug: Panadol-extra

Traditional Treatment

NO INTERVENTION

Patients will not undergo any actual irradiation therapy or take any active tablets during orthodontic treatment.

Interventions

low-level laser therapy will be used to relieve pain and discomfort during orthodontic treatment at specific time points.

Low-level laser therapy

Tablets of 565-mg Panadol-extra will be used at specific time points to control pain and discomfort

Panadol-extra

Eligibility Criteria

Age15 Years - 30 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Class I malocclusion with mild to moderate crowding (2-5 mm of tooth-size-arch-length-discrepancy)..
  • Good oral hygiene and periodontal health
  • No need for any preparation for fixed orthodontic appliance.
  • No severe skeletal discrepancy (i.e. Class I skeletal relationship).

You may not qualify if:

  • Previous orthodontic treatment
  • Patients with psychological abnormalities.
  • Patients with systematic diseases or being treated from chronic pain or headache.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Orthodontics, University of Damascus Dental School

Damascus, DM20AM18, Syria

Location

Related Publications (8)

  • Artes-Ribas M, Arnabat-Dominguez J, Puigdollers A. Analgesic effect of a low-level laser therapy (830 nm) in early orthodontic treatment. Lasers Med Sci. 2013 Jan;28(1):335-41. doi: 10.1007/s10103-012-1135-y. Epub 2012 Jul 21.

    PMID: 22814893BACKGROUND
  • Choi SH, Kim JS, Cha JY, Hwang CJ. Effect of malocclusion severity on oral health-related quality of life and food intake ability in a Korean population. Am J Orthod Dentofacial Orthop. 2016 Mar;149(3):384-90. doi: 10.1016/j.ajodo.2015.08.019.

    PMID: 26926026BACKGROUND
  • Dominguez A, Velasquez SA. Effect of low-level laser therapy on pain following activation of orthodontic final archwires: a randomized controlled clinical trial. Photomed Laser Surg. 2013 Jan;31(1):36-40. doi: 10.1089/pho.2012.3360. Epub 2012 Dec 16.

    PMID: 23240876BACKGROUND
  • Farzanegan F, Zebarjad SM, Alizadeh S, Ahrari F. Pain reduction after initial archwire placement in orthodontic patients: a randomized clinical trial. Am J Orthod Dentofacial Orthop. 2012 Feb;141(2):169-73. doi: 10.1016/j.ajodo.2011.06.042.

    PMID: 22284284BACKGROUND
  • Gupta M, Kandula S, Laxmikanth SM, Vyavahare SS, Reddy SB, Ramachandra CS. Controlling pain during orthodontic fixed appliance therapy with non-steroidal anti-inflammatory drugs (NSAID): a randomized, double-blinded, placebo-controlled study. J Orofac Orthop. 2014 Nov;75(6):471-6. doi: 10.1007/s00056-014-0243-7. Epub 2014 Oct 31.

    PMID: 25355194BACKGROUND
  • Kim WT, Bayome M, Park JB, Park JH, Baek SH, Kook YA. Effect of frequent laser irradiation on orthodontic pain. A single-blind randomized clinical trial. Angle Orthod. 2013 Jul;83(4):611-6. doi: 10.2319/082012-665.1. Epub 2012 Dec 14.

    PMID: 23241006BACKGROUND
  • Long H, Wang Y, Jian F, Liao LN, Yang X, Lai WL. Current advances in orthodontic pain. Int J Oral Sci. 2016 Jun 30;8(2):67-75. doi: 10.1038/ijos.2016.24.

    PMID: 27341389BACKGROUND
  • Owayda AM, Hajeer MY, Al-Sabbagh R, Burhan AS, Darwich K, Aljabban O, Latifeh Y. A randomized controlled trial on the effectiveness of low-level laser therapy versus paracetamol-caffeine for pain control during overall orthodontic treatment. Sci Rep. 2025 Aug 22;15(1):30839. doi: 10.1038/s41598-025-16658-2.

MeSH Terms

Conditions

Pain

Interventions

Low-Level Light Therapy

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Laser TherapyTherapeuticsPhototherapy

Study Officials

  • Amer M Owayda, DDS

    MSc student in Orthodontics, University of Damascus Dental School, Damascus, Syria

    PRINCIPAL INVESTIGATOR
  • Mohammad Y Hajeer, DDS MSc PhD

    Associate Professor of Orthodontics, Department of Orthodontics, University of Damascus Dental School, Damascus, Syria

    STUDY CHAIR
  • Rashad T Murad, DDS MSc PhD

    Associate Professor of Toxins and Pharmaceutics , Faculty of Pharmacology, University of Damascus, Damascus, Syria

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Patients in the first group will undergo active irradiation with low-level laser therapy but they will consume placebo tablets. Patients in the second group will consume real Panadol-extra tablets but they will be subjected to a placebo red-beam as if they are irradiated with a laser beam. Patients in the third group will be subjected to both placebo procedures (i.e. placebo red-beam and not low-level laser therapy and placebo tablets).
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 9, 2018

First Posted

January 17, 2018

Study Start

September 15, 2017

Primary Completion

March 15, 2019

Study Completion

July 1, 2019

Last Updated

July 18, 2019

Record last verified: 2019-07

Data Sharing

IPD Sharing
Will not share

Locations